These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 16170462

  • 21. Applications of gene therapy for familial amyloidotic polyneuropathy.
    Nakamura M, Ando Y.
    Expert Opin Biol Ther; 2004 Oct; 4(10):1621-7. PubMed ID: 15461573
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A New Folding Kinetic Mechanism for Human Transthyretin and the Influence of the Amyloidogenic V30M Mutation.
    Jesus CS, Almeida ZL, Vaz DC, Faria TQ, Brito RM.
    Int J Mol Sci; 2016 Aug 31; 17(9):. PubMed ID: 27589730
    [Abstract] [Full Text] [Related]

  • 24. In vitro modelling of familial amyloidotic polyneuropathy allows quantitative detection of transthyretin amyloid fibril-like structures in hepatic derivatives of patient-specific induced pluripotent stem cells.
    Hoepfner J, Kleinsorge M, Papp O, Alfken S, Heiringhoff R, Pich A, Sauer V, Zibert A, Göhring G, Schmidt H, Sgodda M, Cantz T.
    Biol Chem; 2017 Jul 26; 398(8):939-954. PubMed ID: 28051995
    [Abstract] [Full Text] [Related]

  • 25. Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation.
    Oshima T, Kawahara S, Ueda M, Kawakami Y, Tanaka R, Okazaki T, Misumi Y, Obayashi K, Yamashita T, Ohya Y, Ihse E, Shinriki S, Tasaki M, Jono H, Asonuma K, Inomata Y, Westermark P, Ando Y.
    J Neurol Neurosurg Psychiatry; 2014 Jul 26; 85(7):740-6. PubMed ID: 24023270
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy.
    Tsuchiya-Suzuki A, Yazaki M, Sekijima Y, Kametani F, Ikeda S.
    Amyloid; 2013 Sep 26; 20(3):156-63. PubMed ID: 23826783
    [Abstract] [Full Text] [Related]

  • 31. Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.
    Araki S, Ando Y.
    Proc Jpn Acad Ser B Phys Biol Sci; 2010 Sep 26; 86(7):694-706. PubMed ID: 20689228
    [Abstract] [Full Text] [Related]

  • 32. [Familial amyloid polyneuropathy].
    Yamashita T, Ando Y, Uchino M.
    Brain Nerve; 2011 Jun 26; 63(6):583-95. PubMed ID: 21613661
    [Abstract] [Full Text] [Related]

  • 33. Familial amyloid polyneuropathy.
    Barreiros AP, Galle PR, Otto G.
    Dig Dis; 2013 Jun 26; 31(1):170-4. PubMed ID: 23797140
    [Abstract] [Full Text] [Related]

  • 34. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
    Sekijima Y, Ueda M, Koike H, Misawa S, Ishii T, Ando Y.
    Orphanet J Rare Dis; 2018 Jan 17; 13(1):6. PubMed ID: 29343286
    [Abstract] [Full Text] [Related]

  • 35. The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution.
    Quintas A, Saraiva MJ, Brito RM.
    FEBS Lett; 1997 Dec 01; 418(3):297-300. PubMed ID: 9428731
    [Abstract] [Full Text] [Related]

  • 36. SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy.
    Ueda M, Misumi Y, Mizuguchi M, Nakamura M, Yamashita T, Sekijima Y, Ota K, Shinriki S, Jono H, Ikeda S, Suhr OB, Ando Y.
    Clin Chem; 2009 Jun 01; 55(6):1223-7. PubMed ID: 19372189
    [Abstract] [Full Text] [Related]

  • 37. Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver.
    Takei Y, Gono T, Yazaki M, Ikeda S, Ikegami T, Hashikura Y, Miyagawa S, Hoshii Y.
    Liver Transpl; 2007 Feb 01; 13(2):215-8. PubMed ID: 17029284
    [Abstract] [Full Text] [Related]

  • 38. [The ocular involvement in the transthyretin-related familial amyloid polyneuropathy].
    Lin HY, Dai RP.
    Zhonghua Yan Ke Za Zhi; 2017 Oct 11; 53(10):783-785. PubMed ID: 29050191
    [Abstract] [Full Text] [Related]

  • 39. Familial amyloidotic polyneuropathy: protein aggregation in the peripheral nervous system.
    João Saraiva M, Mendes Sousa M, Cardoso I, Fernandes R.
    J Mol Neurosci; 2004 Oct 11; 23(1-2):35-40. PubMed ID: 15126690
    [Abstract] [Full Text] [Related]

  • 40. Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis.
    Liang Y, Ore MO, Morin S, Wilson DJ.
    Biochemistry; 2012 Apr 24; 51(16):3523-30. PubMed ID: 22482799
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.